Literature DB >> 31907387

Genetic screening for potassium channel mutations in Japanese autosomal dominant spinocerebellar ataxia.

Yui Tada1,2, Kodai Kume1, Yukiko Matsuda1, Takashi Kurashige3, Yuhei Kanaya1, Ryosuke Ohsawa1, Hiroyuki Morino1, Hayato Tabu4, Satoshi Kaneko5, Toshihiko Suenaga6, Akira Kakizuka2, Hideshi Kawakami7.   

Abstract

Spinocerebellar ataxia (SCA) is a genetically heterogeneous disease characterized by cerebellar ataxia. Many causative genes have been identified to date, the most common etiology being the abnormal expansion of repeat sequences, and the mutation of ion channel genes also play an important role in the development of SCA. Some of them encode calcium and potassium channels. However, due to limited reports about potassium genes in SCA, we screened 192 Japanese individuals with dominantly inherited SCA who had no abnormal repeat expansions of causative genes for potassium channel mutations (KCNC3 for SCA13 and KCND3 for SCA19/SCA22) by target sequencing. As a result, two variants were identified from two patients: c.1973G>A, p.R658Q and c.1018G>A, p.V340M for KCNC3, and no pathogenic variant was identified for KCND3. The newly identified p.V340M exists in the extracellular domain, and p.R658Q exists in the intracellular domain on the C-terminal side, although most of the reported KCNC3 mutations are present at the transmembrane site. Adult-onset and slowly progressive cerebellar ataxia are the main clinical features of SCA13 and SCA19 caused by potassium channel mutations, which was similar in our cases. SCA13 caused by KCNC3 mutations may present with deep sensory loss and cognitive impairment in addition to cerebellar ataxia. In this study, mild deep sensory loss was observed in one case. SCA caused by potassium channel gene mutations is extremely rare, and more cases should be accumulated in the future to elucidate its pathogenesis due to channel dysfunction.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31907387     DOI: 10.1038/s10038-019-0717-y

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  21 in total

1.  Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome.

Authors:  John R Giudicessi; Dan Ye; David J Tester; Lia Crotti; Alessandra Mugione; Vladislav V Nesterenko; Richard M Albertson; Charles Antzelevitch; Peter J Schwartz; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2011-02-22       Impact factor: 6.343

2.  Expanding the phenotype of SCA19/22: Parkinsonism, cognitive impairment and epilepsy.

Authors:  Vincent Huin; Isabelle Strubi-Vuillaume; Kathy Dujardin; Marine Brion; Marie Delliaux; Delphine Dellacherie; Jean-Christophe Cuvellier; Jean-Marie Cuisset; Audrey Riquet; Caroline Moreau; Luc Defebvre; Bernard Sablonnière; David Devos
Journal:  Parkinsonism Relat Disord       Date:  2017-09-19       Impact factor: 4.891

3.  Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes.

Authors:  Michael F Waters; Natali A Minassian; Giovanni Stevanin; Karla P Figueroa; John P A Bannister; Dagmar Nolte; Allan F Mock; Virgilio Gerald H Evidente; Dominic B Fee; Ulrich Müller; Alexandra Dürr; Alexis Brice; Diane M Papazian; Stefan M Pulst
Journal:  Nat Genet       Date:  2006-02-26       Impact factor: 38.330

4.  SCA42 mutation analysis in a case series of Japanese patients with spinocerebellar ataxia.

Authors:  Mari Kimura; Ichiro Yabe; Yuka Hama; Katsuki Eguchi; Shigehisa Ura; Kazufumi Tsuzaka; Shoji Tsuji; Hidenao Sasaki
Journal:  J Hum Genet       Date:  2017-05-11       Impact factor: 3.172

5.  De novo mutation screening in childhood-onset cerebellar atrophy identifies gain-of-function mutations in the CACNA1G calcium channel gene.

Authors:  Jean Chemin; Karine Siquier-Pernet; Michaël Nicouleau; Giulia Barcia; Ali Ahmad; Daniel Medina-Cano; Sylvain Hanein; Nami Altin; Laurence Hubert; Christine Bole-Feysot; Cécile Fourage; Patrick Nitschké; Julien Thevenon; Marlène Rio; Pierre Blanc; Céline Vidal; Nadia Bahi-Buisson; Isabelle Desguerre; Arnold Munnich; Stanislas Lyonnet; Nathalie Boddaert; Emily Fassi; Marwan Shinawi; Holly Zimmerman; Jeanne Amiel; Laurence Faivre; Laurence Colleaux; Philippe Lory; Vincent Cantagrel
Journal:  Brain       Date:  2018-07-01       Impact factor: 13.501

6.  Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel.

Authors:  O Zhuchenko; J Bailey; P Bonnen; T Ashizawa; D W Stockton; C Amos; W B Dobyns; S H Subramony; H Y Zoghbi; C C Lee
Journal:  Nat Genet       Date:  1997-01       Impact factor: 38.330

7.  Mutations in KCND3 cause spinocerebellar ataxia type 22.

Authors:  Yi-Chung Lee; Alexandra Durr; Karen Majczenko; Yen-Hua Huang; Yu-Chao Liu; Cheng-Chang Lien; Pei-Chien Tsai; Yaeko Ichikawa; Jun Goto; Marie-Lorraine Monin; Jun Z Li; Ming-Yi Chung; Emeline Mundwiller; Vikram Shakkottai; Tze-Tze Liu; Christelle Tesson; Yi-Chun Lu; Alexis Brice; Shoji Tsuji; Margit Burmeister; Giovanni Stevanin; Bing-Wen Soong
Journal:  Ann Neurol       Date:  2012-12       Impact factor: 10.422

8.  Novel De Novo KCND3 Mutation in a Japanese Patient with Intellectual Disability, Cerebellar Ataxia, Myoclonus, and Dystonia.

Authors:  Masanori Kurihara; Hiroyuki Ishiura; Takuya Sasaki; Juuri Otsuka; Toshihiro Hayashi; Yasuo Terao; Takashi Matsukawa; Jun Mitsui; Juntaro Kaneko; Kazutoshi Nishiyama; Koichiro Doi; Jun Yoshimura; Shinichi Morishita; Jun Shimizu; Shoji Tsuji
Journal:  Cerebellum       Date:  2018-04       Impact factor: 3.847

9.  De novo point mutations in patients diagnosed with ataxic cerebral palsy.

Authors:  Ricardo Parolin Schnekenberg; Emma M Perkins; Jack W Miller; Wayne I L Davies; Maria Cristina D'Adamo; Mauro Pessia; Katherine A Fawcett; David Sims; Elodie Gillard; Karl Hudspith; Paul Skehel; Jonathan Williams; Mary O'Regan; Sandeep Jayawant; Rosalind Jefferson; Sarah Hughes; Andrea Lustenberger; Jiannis Ragoussis; Mandy Jackson; Stephen J Tucker; Andrea H Németh
Journal:  Brain       Date:  2015-05-16       Impact factor: 13.501

10.  Exome sequencing in undiagnosed inherited and sporadic ataxias.

Authors:  Angela Pyle; Tania Smertenko; David Bargiela; Helen Griffin; Jennifer Duff; Marie Appleton; Konstantinos Douroudis; Gerald Pfeffer; Mauro Santibanez-Koref; Gail Eglon; Patrick Yu-Wai-Man; Venkateswaran Ramesh; Rita Horvath; Patrick F Chinnery
Journal:  Brain       Date:  2014-12-12       Impact factor: 13.501

View more
  5 in total

1.  Aggressive periodontitis and NOD2 variants.

Authors:  Noriyoshi Mizuno; Kodai Kume; Yukiko Nagatani; Shinji Matsuda; Tomoyuki Iwata; Kazuhisa Ouhara; Mikihito Kajiya; Katsuhiro Takeda; Yukiko Matsuda; Yui Tada; Ryosuke Ohsawa; Hiroyuki Morino; Keichiro Mihara; Tsuyoshi Fujita; Hiroyuki Kawaguchi; Hideki Shiba; Hideshi Kawakami; Hidemi Kurihara
Journal:  J Hum Genet       Date:  2020-05-19       Impact factor: 3.172

2.  Timing is everything: structural insights into the disease-linked Kv3 channels controlling fast action-potential firing in the brain.

Authors:  Martin J Gunthorpe
Journal:  Nat Commun       Date:  2022-07-15       Impact factor: 17.694

3.  Trigeminal Neuralgia TRPM8 Mutation: Enhanced Activation, Basal [Ca2+]i and Menthol Response.

Authors:  Roberta Gualdani; Jun-Hui Yuan; Philip R Effraim; Giulia Di Stefano; Andrea Truini; Giorgio Cruccu; Sulayman D Dib-Hajj; Philippe Gailly; Stephen G Waxman
Journal:  Neurol Genet       Date:  2021-01-11

4.  Prediction Model of Amyotrophic Lateral Sclerosis by Deep Learning with Patient Induced Pluripotent Stem Cells.

Authors:  Keiko Imamura; Yuichiro Yada; Yuishin Izumi; Mitsuya Morita; Akihiro Kawata; Takayo Arisato; Ayako Nagahashi; Takako Enami; Kayoko Tsukita; Hideshi Kawakami; Masanori Nakagawa; Ryosuke Takahashi; Haruhisa Inoue
Journal:  Ann Neurol       Date:  2021-02-25       Impact factor: 10.422

Review 5.  Milestones in genetics of cerebellar ataxias.

Authors:  Magdalena Krygier; Maria Mazurkiewicz-Bełdzińska
Journal:  Neurogenetics       Date:  2021-07-05       Impact factor: 2.660

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.